In February 2024, the United Judicial Panel on Multidistrict Litigation (JPML) ordered the consolidation of Suboxone dental injury lawsuits as centralized in the U.S. District Court for the Northern District of Ohio under Judge J. Phillip Calabrese. (Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation, 1:24-md-3092).

At the time of the writing of this article, roughly 150 cases have been filed in, or transferred to, the consolidated multidistrict litigation (MDL), with more filings anticipated soon due to the recent entry of a direct filing order. Defendants currently include Reckitt Benckiser Pharmaceuticals and Indivior. In 2014, Reckitt Benckiser turned its specialty pharmaceuticals business into a separate company called Indivior.